Arkolith/Insider Trading/PPCB/Form 4

Nathanielsz James Andrew

CEO/CFO, DirectorPropanc Biopharma, Inc. (PPCB) · full profile →Form 4 · filed Aug 20, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 17, 2021Grant(A)5.9M—$05.9M
Aug 17, 2021Grant(A)2.8M—$02.8M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-21-020758) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML